However, there is little prospect of efficacy with MDM2 inhibitors alone in therapy (70), MDM2 suppression was linked to elevated p53 protein expression in pre-clinical and clinical studies, but it was not linked to an improvement in the results of tumour growth suppression or prolonged survival (71). This evidence concerns the gene TP53 and neoplasm.